Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Arango, C; Dragioti, E; Solmi, M; Cortese, S; Domschke, K; Murray, RM; Jones, PB; Uher, R; Carvalho, AF; Reichenberg, A; Shin, JI; Andreassen, OA; Correll, CU; Fusar-Poli, P.

Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas

World Psychiatry. 2021; 20(3): 417-436 Nº de citas: 187 [doi:10.1002/wps.20894]

Ferraro, L; La Cascia, C; La Barbera, D; Sanchez-Gutierrez, T; Tripoli, G; Seminerio, F; Sartorio, C; Marrazzo, G; Sideli, L; Arango, C; Arrojo, M; Bernardo, M; Bobes, J; Del-Ben, CM; Gayer-Anderson, C; Jongsma, HE; Kirkbride, JB; Lasalvia, A; Tosato, S; Llorca, PM; Menezes, PR; Rutten, BP; Santos, JL; Sanjuan, J; Selten, JP; Szoke, A; Tarricone, I; Muratori, R; Tortelli, A; Velthorst, E; Rodriguez, V; Quattrone, A; Jones, PB; Van Os, J; Vassos, E; Morgan, C; de Haan, L; Reininghaus, U; Cardno, AG; Di Forti, M; Murray, RM; Quattrone, D.

The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study

SCHIZOPHRENIA RESEARCH. 2021; 236: 69-79 Nº de citas: 8 [doi:10.1016/j.schres.2021.08.008]

Gonzalez-Blanco, L; Garcia-Portilla, MP; Gutierrez, M; Mezquida, G; Cuesta, MJ; Urbiola, E; Amoretti, S; Barcones, F; Gonzalez-Pinto, A; Pina-Camacho, L; Corripio, I; Vieta, E; Baeza, I; Toll, A; Saiz, PA; Bobes, J; Bernardo, M; PEPs Grp.

Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

SCHIZOPHRENIA RESEARCH. 2021; 236: 19-28 Nº de citas: 7 [doi:10.1016/j.schres.2021.07.017]

Rapado-Castro, M; Villar-Arenzana, M; Janssen, J; Fraguas, D; Bombin, I; Castro-Fornieles, J; Mayoral, M; Gonzalez-Pinto, A; de la Serna, E; Parellada, M; Moreno, D; Paya, B; Graell, M; Baeza, I; Pantelis, C; Arango, C.

Fronto-Parietal Gray Matter Volume Loss Is Associated with Decreased Working Memory Performance in Adolescents with a First Episode of Psychosis

Journal of Clinical Medicine. 2021; 10(17): Nº de citas: 4 [doi:10.3390/jcm10173929]

Ballesteros, A; Torres, AMS; Lopez-Ilundain, J; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Pina-Camacho, L; Corripio, I; Vieta, E; de la Serna, E; Mane, A; Bioque, M; Moreno-Izco, L; Espliego, A; Lorente-Omenaca, R; Amoretti, S; Bernardo, M; Cuesta, MJ; PEPs Grp.

The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory

PSYCHOLOGICAL MEDICINE. 2021; 51(12): 2044-2053 Nº de citas: 6 [doi:10.1017/S003329172000080X]

Sami, M; Quattrone, D; Ferraro, L; Tripoli, G; La Cascia, E; Gayer-Anderson, C; Selten, JP; Arango, C; Bernardo, M; Tarricone, I; Tortelli, A; Gatto, G; del Peschio, S; Del-Ben, CM; Rutten, BP; Jones, PB; van Os, J; de Haan, L; Morgan, C; Lewis, C; Bhattacharyya, S; Freeman, TP; Lynskey, M; Murray, RM; Di Forti, M.

Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls

PSYCHOLOGICAL MEDICINE. 2021; 51(12): 2074-2082 Nº de citas: 8 [doi:10.1017/S0033291720000847]

Valencia, F; Penelo, E; de la Osa, N; Navarro, JB; Ezpeleta, L.

Prospective association of parental and child internalizing symptoms: Mediation of parenting practices and irritability

BRITISH JOURNAL OF DEVELOPMENTAL PSYCHOLOGY. 2021; 39(3): 363-379 Nº de citas: 3 [doi:10.1111/bjdp.12367]

Persico, AM; Ricciardello, A; Lamberti, M; Turriziani, L; Cucinotta, F; Brogna, C; Vitiello, B; Arango, C.

The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2021; 110: 110326-110326 Nº de citas: 71 [doi:10.1016/j.pnpbp.2021.110326]

Parellada, M; Caceres, ASJ; Palmer, M; Delorme, R; Jones, EJH; Parr, JR; Anagnostou, E; Murphy, DGM; Loth, E; Wang, PP; Charman, T; Strydom, A; Arango, C; AIMS-2-TRIALS-CT1 Grp.

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

Frontiers in Psychiatry. 2021; 12: 701729-701729 Nº de citas: 10 [doi:10.3389/fpsyt.2021.701729]

Panchal, U; de Pablo, GS; Franco, M; Moreno, C; Parellada, M; Arango, C; Fusar-Poli, P.

The impact of COVID-19 lockdown on child and adolescent mental health: systematic review

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 32(7): 1-27 Nº de citas: 644 [doi:10.1007/s00787-021-01856-w]

Martinez-Pinteno, A; Gasso, P; Prohens, L; Segura, AG; Parellada, M; Saiz-Ruiz, J; Cuesta, MJ; Bernardo, M; Lafuente, A; Mas, S; Rodriguez, N.

Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

Frontiers in Pharmacology. 2021; 12: 729474-729474 Nº de citas: 2 [doi:10.3389/fphar.2021.729474]

Quattrone, D; Reininghaus, U; Richards, AL; Tripoli, G; Ferraro, L; Quattrone, A; Marino, P; Rodriguez, V; Spinazzola, E; Gayer-Anderson, C; Jongsma, HE; Jones, PB; La Cascia, C; La Barbera, D; Tarricone, I; Bonora, E; Tosato, S; Lasalvia, A; Szoke, A; Arango, C; Bernardo, M; Bobes, J; Del Ben, CM; Menezes, PR; Llorca, PM; Santos, JL; Sanjuan, J; Arrojo, M; Tortelli, A; Velthorst, E; Berendsen, S; de Haan, L; Rutten, BPF; Lynskey, MT; Freeman, TP; Kirkbride, JB; Sham, PC; O'Donovan, MC; Cardno, AG; Vassos, E; van Os, J; Morgan, C; Murray, RM; Lewis, CM; Di Forti, M; EU-GEI Collaborators.

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

Translational Psychiatry. 2021; 11(1): Nº de citas: 11 [doi:10.1038/s41398-021-01526-0]

Martin-Babarro, J; Toldos, MP; Paredes-Becerra, L; Abregu-Crespo, R; Fernandez-Sanchez, J; Diaz-Caneja, CM.

Association of Different Forms of Child Maltreatment With Peer Victimization in Mexican Children and Adolescents

FRONTIERS IN PSYCHOLOGY. 2021; 12: 662121-662121 Nº de citas: 10 [doi:10.3389/fpsyg.2021.662121]

Verdolini, N; Amoretti, S; Mezquida, G; Cuesta, MJ; Pina-Camacho, L; Garcia-Rizo, C; Lobo, A; Gonzalez-Pinto, A; Merchan-Naranjo, J; Corripio, I; Salagre, E; Baeza, I; Berge, D; Garriga, M; Bioque, M; Vallespir, C; Serra, M; Vieta, E; Bernardo, M.

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 49: 54-68 Nº de citas: 9 [doi:10.1016/j.euroneuro.2021.03.015]

Bralten, J; Mota, NR; Klemann, CJHM; De Witte, W; Laing, E; Collier, DA; de Kluiver, H; Bauduin, SEEC; Arango, C; Ayuso-Mateos, JL; Fabbri, C; Kas, MJ; van der Wee, N; Penninx, BWJH; Serretti, A; Franke, B; Poelmans, G.

Genetic underpinnings of sociability in the general population

NEUROPSYCHOPHARMACOLOGY. 2021; 46(9): 1627-1634 Nº de citas: 34 [doi:10.1038/s41386-021-01044-z]

Velthorst, E; Mollon, J; Murray, RM; de Haan, L; Germeys, IM; Glahn, DC; Arango, C; van der Ven, E; Di Forti, M; Bernardo, M; Guloksuz, S; Delespaul, P; Mezquida, G; Amoretti, S; Bobes, J; Saiz, PA; Garcia-Portilla, MP; Santos, JL; Jimenez-Lopez, E; Sanjuan, J; Aguilar, EJ; Arrojo, M; Carracedo, A; Lopez, G; Gonzalez-Penas, J; Parellada, M; Atbasoglu, C; Saka, MC; Ucok, A; Alptekin, K; Akdede, B; Binbay, T; Altinyazar, V; Ulas, H; Yalincetin, B; Gumus-AkaY, G; Beyaz, BC; Soygur, H; Cankurtaran, ES; Kaymak, SU; Maric, NP; Mihaljevic, MM; Petrovic, SA; Mirjanic, T; Del-Ben, CM; Ferraro, L; Gayer-Anderson, C; Jones, PB; Jongsma, HE; Kirkbride, JB; La Cascia, C; Lasalvia, A; Tosato, S; Llorca, PM; Menezes, PR; Morgan, C; Quattrone, D; Menchetti, M; Selten, JP; Szoke, A; Tarricone, I; Tortelli, A; McGuire, P; Valmaggia, L; Kempton, MJ; van der Gaag, M; Riecher-Rossler, A; Bressan, RA; Barrantes-Vidal, N; Nelson, B; McGorry, P; Pantelis, C; Krebs, MO; Ruhrmann, S; Sachs, G; Rutten, BPF; van Os, J; Alizadeh, BZ; van Amelsvoort, T; Bartels-Velthuis, AA; Bruggeman, R; van Beveren, NJ; Luykx, JJ; Cahn, W; Simons, CJP; Kahn, RS; Schirmbeck, F; van Winkel, R; Reichenberg, A; EU-GEI High Risk Study.

Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

MOLECULAR PSYCHIATRY. 2021; 26(8): 4529-4543 Nº de citas: 31 [doi:10.1038/s41380-020-00969-z]

Crutel, V; Lambert, E; Penelaud, PF; Severo, CA; Fuentes, J; Rosier, A; Hervas, A; Marret, S; Oliveira, G; Parellada, M; Kyaga, S; Gouttefangeas, S; Bertrand, M; Ravel, D; Falissard, B.

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. 2021; 51(8): 2959-2972 Nº de citas: 16 [doi:10.1007/s10803-020-04709-8]

Werhahn, JE; Mohl, S; Willinger, D; Smigielski, L; Roth, A; Hofstetter, C; Stampfli, P; Naaijen, J; Mulder, LM; Glennon, JC; Hoekstra, PJ; Dietrich, A; Deters, RK; Aggensteiner, PM; Holz, NE; Baumeister, S; Banaschewski, T; Saam, MC; Schulze, UME; Lythgoe, DJ; Sethi, A; Craig, MC; Mastroianni, M; Sagar-Ouriaghli, I; Santosh, PJ; Rosa, M; Bargallo, N; Castro-Fornieles, J; Arango, C; Penzo, MJ; Zwiers, MP; Franke, B; Buitelaar, JK; Walitza, S; Brandeis, D.

Aggression subtypes relate to distinct resting state functional connectivity in children and adolescents with disruptive behavior

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 30(8): 1237-1249 Nº de citas: 31 [doi:10.1007/s00787-020-01601-9]